Table of Contents Author Guidelines Submit a Manuscript
Disease Markers
Volume 2017 (2017), Article ID 1372387, 8 pages
https://doi.org/10.1155/2017/1372387
Research Article

Expression of Autophagy-Related Proteins in Hürthle Cell Neoplasm Is Different from That in Follicular Neoplasm

Department of Pathology, Yonsei University College of Medicine, Seoul, Republic of Korea

Correspondence should be addressed to Ja Seung Koo

Received 22 February 2017; Revised 23 June 2017; Accepted 5 July 2017; Published 27 July 2017

Academic Editor: Stamatios E. Theocharis

Copyright © 2017 Yoon Jin Cha et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. B. Levine and D. J. Klionsky, “Development by self-digestion: molecular mechanisms and biological functions of autophagy,” Developmental Cell, vol. 6, no. 4, pp. 463–477, 2004. View at Publisher · View at Google Scholar · View at Scopus
  2. N. Mizushima, “Autophagy: process and function,” Genes & Development, vol. 21, no. 22, pp. 2861–2873, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. N. Mizushima, B. Levine, A. M. Cuervo, and D. J. Klionsky, “Autophagy fights disease through cellular self-digestion,” Nature, vol. 451, no. 7182, pp. 1069–1075, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. Z. Yang and D. J. Klionsky, “Eaten alive: a history of macroautophagy,” Nature Cell Biology, vol. 12, no. 9, pp. 814–822, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. Y. Chen, Y. Lu, C. Lu, and L. Zhang, “Beclin-1 expression is a predictor of clinical outcome in patients with esophageal squamous cell carcinoma and correlated to hypoxia-inducible factor (HIF)-1α expression,” Pathology Oncology Research, vol. 15, no. 3, pp. 487–493, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. B. X. Li, C. Y. Li, R. Q. Peng et al., “The expression of beclin 1 is associated with favorable prognosis in stage IIIB colon cancers,” Autophagy, vol. 5, no. 3, pp. 303–306, 2009. View at Google Scholar
  7. L. Pirtoli, G. Cevenini, P. Tini et al., “The prognostic role of beclin 1 protein expression in high-grade gliomas,” Autophagy, vol. 5, no. 7, pp. 930–936, 2009. View at Google Scholar
  8. X. B. Wan, X. J. Fan, M. Y. Chen et al., “Elevated beclin 1 expression is correlated with HIF-1alpha in predicting poor prognosis of nasopharyngeal carcinoma,” Autophagy, vol. 6, no. 3, pp. 395–404, 2010. View at Google Scholar
  9. Y. Kabeya, N. Mizushima, T. Ueno et al., “LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing,” The EMBO Journal, vol. 19, no. 21, pp. 5720–5728, 2000. View at Publisher · View at Google Scholar
  10. E. Sivridis, M. I. Koukourakis, C. E. Zois et al., “LC3A-positive light microscopy detected patterns of autophagy and prognosis in operable breast carcinomas,” The American Journal of Pathology, vol. 176, no. 5, pp. 2477–2489, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. A. Yoshioka, H. Miyata, Y. Doki et al., “LC3, an autophagosome marker, is highly expressed in gastrointestinal cancers,” International Journal of Oncology, vol. 33, no. 3, pp. 461–468, 2008. View at Google Scholar
  12. M. Komatsu, S. Waguri, M. Koike et al., “Homeostatic levels of p62 control cytoplasmic inclusion body formation in autophagy-deficient mice,” Cell, vol. 131, no. 6, pp. 1149–1163, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. N. Mizushima, T. Yoshimori, and B. Levine, “Methods in mammalian autophagy research,” Cell, vol. 140, no. 3, pp. 313–326, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. T. Zhang, L. Xue, L. Li et al., “BNIP3 protein suppresses PINK1 kinase proteolytic cleavage to promote mitophagy,” The Journal of Biological Chemistry, vol. 291, no. 41, pp. 21616–21629, 2016. View at Publisher · View at Google Scholar · View at Scopus
  15. K. Degenhardt, R. Mathew, B. Beaudoin et al., “Autophagy promotes tumor cell survival and restricts necrosis, inflammation, and tumorigenesis,” Cancer Cell, vol. 10, no. 1, pp. 51–64, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. S. Roy and J. Debnath, “Autophagy and tumorigenesis,” Seminars in Immunopathology, vol. 32, no. 4, pp. 383–396, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. E. H. Baehrecke, “Autophagy: dual roles in life and death?” Nature Reviews. Molecular Cell Biology, vol. 6, no. 6, pp. 505–510, 2005. View at Publisher · View at Google Scholar · View at Scopus
  18. J. Debnath, E. H. Baehrecke, and G. Kroemer, “Does autophagy contribute to cell death?” Autophagy, vol. 1, no. 2, pp. 66–74, 2005. View at Google Scholar
  19. P. I. Haigh and D. R. Urbach, “The treatment and prognosis of Hürthle cell follicular thyroid carcinoma compared with its non-Hürthle cell counterpart,” Surgery, vol. 138, no. 6, pp. 1152–1158, 2005. View at Publisher · View at Google Scholar · View at Scopus
  20. S. A. Hundahl, B. Cady, M. P. Cunningham et al., “Initial results from a prospective cohort study of 5583 cases of thyroid carcinoma treated in the united states during 1996. U.S. and German Thyroid Cancer Study Group. An American College of Surgeons Commission on Cancer Patient Care Evaluation study,” Cancer, vol. 89, no. 1, pp. 202–217, 2000. View at Publisher · View at Google Scholar
  21. Y. Nikiforov, P. W. Biddinger, and L. D. R. Thompson, Diagnostic Pathology and Molecular Genetics of the Thyroid, Wolters Kluwer Health/Lippincott Williams & Wilkins, Philadelphia, 2012.
  22. R. A. DeLellis and C. International Agency for Research on, O. World Health, and P. International Academy of, Pathology and Genetics of Tumours of Endocrine Organs, IARC Press, Lyon, 2004.
  23. K. Sugino, K. Kameyama, K. Ito et al., “Does Hürthle cell carcinoma of the thyroid have a poorer prognosis than ordinary follicular thyroid carcinoma?” Annals of Surgical Oncology, vol. 20, no. 9, pp. 2944–2950, 2013. View at Publisher · View at Google Scholar · View at Scopus
  24. N. Besic, M. Hocevar, J. Zgajnar, R. Petric, and G. Pilko, “Aggressiveness of therapy and prognosis of patients with Hurthle cell papillary thyroid carcinoma,” Thyroid, vol. 16, no. 1, pp. 67–72, 2006. View at Publisher · View at Google Scholar · View at Scopus
  25. A. M. Chindris, J. D. Casler, V. J. Bernet et al., “Clinical and molecular features of Hurthle cell carcinoma of the thyroid,” The Journal of Clinical Endocrinology and Metabolism, vol. 100, no. 1, pp. 55–62, 2015. View at Publisher · View at Google Scholar · View at Scopus
  26. L. R. Henry, H. O. Lee, J. S. Lee et al., “Clinical implications of fibroblast activation protein in patients with colon cancer,” Clinical Cancer Research, vol. 13, no. 6, pp. 1736–1741, 2007. View at Publisher · View at Google Scholar · View at Scopus
  27. J. Lee, S. Ham, M. H. Lee et al., “Dysregulation of Parkin-mediated mitophagy in thyroid Hurthle cell tumors,” Carcinogenesis, vol. 36, no. 11, pp. 1407–1418, 2015. View at Publisher · View at Google Scholar · View at Scopus
  28. K. T. Montone, Z. W. Baloch, and V. A. LiVolsi, “The thyroid Hurthle (oncocytic) cell and its associated pathologic conditions: a surgical pathology and cytopathology review,” Archives of Pathology & Laboratory Medicine, vol. 132, no. 8, pp. 1241–1250, 2008. View at Publisher · View at Google Scholar
  29. J. Lee, S. Yi, Y. E. Kang et al., “Defective ciliogenesis in thyroid hurthle cell tumors is associated with increased autophagy,” Oncotarget, vol. 7, no. 48, pp. 79117–79130, 2016. View at Publisher · View at Google Scholar · View at Scopus
  30. Y. Hu, X. Li, W. Xue et al., “TP53INP2-related basal autophagy is involved in the growth and malignant progression in human liposarcoma cells,” Biomedicine & Pharmacotherapy, vol. 88, pp. 562–568, 2017. View at Publisher · View at Google Scholar
  31. D. H. Wu, C. C. Jia, J. Chen et al., “Autophagic LC3B overexpression correlates with malignant progression and predicts a poor prognosis in hepatocellular carcinoma,” Tumour Biology, vol. 35, no. 12, pp. 12225–12233, 2014. View at Publisher · View at Google Scholar · View at Scopus
  32. R. K. Amaravadi, D. Yu, J. J. Lum et al., “Autophagy inhibition enhances therapy-induced apoptosis in a Myc-induced model of lymphoma,” The Journal of Clinical Investigation, vol. 117, no. 2, pp. 326–336, 2007. View at Publisher · View at Google Scholar · View at Scopus
  33. J. S. Carew, E. C. Medina, J. A. Esquivel 2nd et al., “Autophagy inhibition enhances vorinostat-induced apoptosis via ubiquitinated protein accumulation,” Journal of Cellular and Molecular Medicine, vol. 14, no. 10, pp. 2448–2459, 2010. View at Publisher · View at Google Scholar · View at Scopus
  34. J. S. Carew, S. T. Nawrocki, C. N. Kahue et al., “Targeting autophagy augments the anticancer activity of the histone deacetylase inhibitor SAHA to overcome Bcr-Abl-mediated drug resistance,” Blood, vol. 110, no. 1, pp. 313–322, 2007. View at Publisher · View at Google Scholar · View at Scopus
  35. A. Gupta, S. Roy, A. J. Lazar et al., “Autophagy inhibition and antimalarials promote cell death in gastrointestinal stromal tumor (GIST),” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 32, pp. 14333–14338, 2010. View at Publisher · View at Google Scholar · View at Scopus